These mice develop a progressive myeloproliferative disorder that has many features of myelofibrosis after 1 year of life and reduced levels of GATA-1 have also been demonstrated in the megakaryocytes of patients with IMF [14,15]. The gene discussed is GATA1; the disease is myeloproliferative disorder.